Relationship of triglyceride-glucose index with cardiometabolic multi-morbidity in China: evidence from a national survey

Table 4 The association of TyG index with CMM in participants without stroke, heart disease or DM at baseline

TyG index	Total N	No. of events (Incident rate^#)	Model 1		Model 2		Model 3
TyG index	Total N	No. of events (Incident rate^#)	HR (95% CI)	P value	HR (95% CI)	P value	HR (95% CI)	P value
Continues
Per 1.0 increase	6744	303 (6.47)	1.71 (1.48–1.98)	< 0.001	1.37 (1.15–1.63)	< 0.001	1.73 (1.35–2.22)	< 0.001
Quartiles
Q1	1687	44 (3.75)	Ref.		Ref.		Ref.
Q2	1687	60 (5.13)	1.30 (0.89–1.91)	0.175	1.11 (0.74–1.66)	0.604	1.08 (0.72–1.62)	0.712
Q3	1684	84 (7.18)	1.92 (1.35–2.74)	< 0.001	1.31 (0.89–1.92)	0.165	1.21 (0.82–1.79)	0.341
Q4	1686	115 (9.85)	2.69 (1.91–3.78)	< 0.001	1.59 (1.09–2.31)	0.016	1.62 (1.07–2.44)	0.022

Model 1: unadjusted
Model 2: adjusted for age, sex, SBP, DBP, BMI, alcohol consumption and smoking status
Model 3: model 2 + further adjusted for marital status, education, rural residence, heart rate, BUN, serum creatinine, UA, hemoglobin, TC, LDL
BMI, body mass index; BUN, blood urea nitrogen; CI, confidence interval; CMM, cardiometabolic multimorbidity; DBP, diastolic blood pressure; DM, diabetes mellitus; HR, hazard ratio; LDL, low density lipoprotein; Q, quartile; Ref, reference; SBP, systolic blood pressure; TC, total cholesterol; UA, uric acid
^#Incident rate was presented as per 1000 person-years of follow-up

ISSN: 1758-5996